Providing Market Intelligence for 40 Years

In The News

TV's next big experiment: 'choose your own adventure'

Viewers vote on the actions of the protagonist -- leading to one of seven endings -- using a smartphone app while the movie keeps rolling seamlessly for between 70 and 90 minutes.

"This type of content has not really been possible on a broad scale until now," Glenn Hower, a senior digital media analyst with research firm Parks Associates, told AFP.

"Sure, it could be done on DVD or Blu-ray discs, but the experience is typically slow and disruptive."

Hower said it would be interesting to see how the format could be incorporated into the booming virtual reality (VR) industry.

"Consuming VR-formatted content is highly personal as it is, and allowing a free or even semi-directed narrative gives consumers the opportunity to make this content even more their own."

From the article "TV's next big experiment: 'choose your own adventure'."

Previously In The News

59% of broadband-enabled UK households now access video content online

The proportion of UK households with broadband connections utilising the service to access online video content has reached 59%, according to new research. Parks Associates relayed their key findin...

AT&T kills Plenti loyalty program but touts ongoing Thanks campaign

Parks Associates reported last year that 60% of respondents in a survey valued a rewards program for being a loyal customers, third only to the ability to roll over unused data (66%) and free access t...

Over Two-Thirds Of U.S. Smartphone Owners Stream Music Daily

A recent Parks Associates report reveals that 68 percent of U.S. smartphone owners listen to streaming music every day, for an average of 45 minutes per day. Amazon Prime Music emerged as the most pop...

Morning Read: Pharma Changes Afoot As Valeant Courts A New CEO And Novartis U.S. Head Exits

Less than half of caregivers with a smartphone use apps aimed at caregivers, according to a report by Parks Associates. — MobiHealthNews From the article "Morning Read: Pharma Changes Afoot As Vale...